CD8A and renal cell carcinoma: Similar to what was observed for primary renal tumor regression, we found that mice lacking CD8 T cells were unable to control metastatic RCC tumor outgrowth following Ad5mTRAIL+CpG therapy, resulting in large tumor burdens similar to those seen in PBS-treated mice (Fig. 6D).